Ivermectin: Major tech breakthrough in human application, as scientists aim to save world from Covid-19 and malaria

Loading player...
* Mountain Valley MD, listed in Canada and Germany, says it has patented the 'Holy Grail' for pharmaceutical companies - the improved solubilisation of drugs.
* It has developed a tabled that dissolves easily, with a fraction of the dose, of wonderdrug Ivermectin.
* Ivermectin is seen by many as the drug to stop Covid-19 in its trackes; Mountain Valley MD is involved in the largest human trial on earth.
* A world shortage of Ivermectin has developed, with prices shooting up 2000% as more people become convinced of its anti-Covid benefits.
* Mountain Valley MD speaks to BizNews about a way to clear Covid-19 faster than any drug on earth.
* This application is on the whiteboard list for trials in treating cancerous tumours. Learn more about your ad choices. Visit megaphone.fm/adchoices
10 Feb 2021 1PM English South Africa Investing · Business News

Other recent episodes

Jacques Broodryk - AfriForum goes after the elusive Guptas…

AfriForum has asked the National Director of Public Prosecutions, Advocate Andy Mothibi, for an urgent update on the much delayed extradition of the Guptas who allegedly benefited from State Capture to the tune of between R50 and R70 billion. In this interview with Chris Steyn, Jacques Broodryk, AfriForum’s Chief Spokesperson:…
21 May 5AM 9 min

BN Daybreak - Thu 21 May 2026: Nvidia; SpaceX; Anthropic; Fed Hikes; Oil Shock; SA Infrastructure; Hartley on BRICS

In today's BizNews Daybreak, Nvidia delivers an upbeat sales forecast and multi-billion-dollar buyback plan, while SpaceX prepares for the world’s largest ever IPO. Meanwhile, Anthropic reports surging Claude revenue, and Fed minutes signal potential interest rate hikes. In global affairs, Middle East tensions cause oil market volatility, raising economic risks…
20 May 11PM 12 min

George Glynos - The Rand's Reckoning

The South African rand looks resilient - but George Glynos warns that appearances are dangerously deceiving. In this interview with Irakli, ETM Analytics Co-Founder and Head of Research lays out exactly why the risks are building asymmetrically against the rand - and why complacency could prove costly. On the scale…
20 May 10AM 11 min

Accretiv doubles down on US industrial property | Webinar

Martin Freeman and Justin Clarke unpack why US industrial real estate — particularly “shallow bay” facilities linked to manufacturing and logistics — is emerging as a standout opportunity. They discuss the impact of AI-driven data centre investment, America’s onshoring push, interest rate dynamics, and Accretiv’s latest Alabama acquisition tied to…
20 May 10AM 42 min